"Mid-P strategy" versus "internal target volume strategy in locally advanced non small cell lung cancer: Clinical results from the randomized non-comparative phase II study Mid-P.
Line ClaudeCamille SchifflerVanina IsnardiSéverine MetzgerSophie DarnisIsabelle Martel-LafayThomas BaudierSimon RitDavid SarrutMyriam AyadiPublished in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2024)
Local control and survival remain poor using the Mid-P strategy in this prospective randomized non-comparative monocentric study investigating Mid-P strategy versus ITV strategy in LA-NSCLC. Since the Mid-P strategy is not integrated into routine software, and perceived as a time-consuming method, Mid-P strategy cannot be recommended in LA-NSCLCC treated by definitive normo-fractionated conformal radiotherapy outside clinical trials.
Keyphrases
- locally advanced
- phase ii study
- open label
- clinical trial
- small cell lung cancer
- rectal cancer
- double blind
- radiation therapy
- randomized controlled trial
- phase ii
- early stage
- neoadjuvant chemotherapy
- depressive symptoms
- phase iii
- mental health
- social support
- radiation induced
- newly diagnosed
- tyrosine kinase
- epidermal growth factor receptor